These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 34767343)

  • 1. Antitumor Effects of Ir(III)-2
    Panchangam RL; Rao RN; Balamurali MM; Hingamire TB; Shanmugam D; Manickam V; Chanda K
    Inorg Chem; 2021 Dec; 60(23):17593-17607. PubMed ID: 34767343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Antitumor Activity Evaluation of Cyclometalated 2H-Indazole Ruthenium(II) and Iridium(III) Complexes.
    Rao RN; Panchangam RL; Manickam V; Balamurali MM; Chanda K
    Chempluschem; 2020 Aug; 85(8):1800-1812. PubMed ID: 32820621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.
    Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A
    Eur J Med Chem; 2024 Oct; 276():116618. PubMed ID: 38972079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Characterization, and Biological Properties of Steroidal Ruthenium(II) and Iridium(III) Complexes Based on the Androst-16-en-3-ol Framework.
    Koch V; Meschkov A; Feuerstein W; Pfeifer J; Fuhr O; Nieger M; Schepers U; Bräse S
    Inorg Chem; 2019 Dec; 58(23):15917-15926. PubMed ID: 31714764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes.
    Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ
    J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
    Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V
    Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339.
    Büchel GE; Kossatz S; Sadique A; Rapta P; Zalibera M; Bucinsky L; Komorovsky S; Telser J; Eppinger J; Reiner T; Arion VB
    Dalton Trans; 2017 Sep; 46(35):11925-11941. PubMed ID: 28850133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
    Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
    Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular Localization Studies of the Luminescent Analogue of an Anticancer Ruthenium Iminophosphorane with High Efficacy in a Triple-Negative Breast Cancer Mouse Model.
    Miachin K; Del Solar V; El Khoury E; Nayeem N; Khrystenko A; Appelt P; Neary MC; Buccella D; Contel M
    Inorg Chem; 2021 Dec; 60(24):19152-19164. PubMed ID: 34846878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
    J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
    Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
    Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer activity and mechanism studies of photoactivated iridium(III) complexes toward lung cancer A549 cells.
    Zhou L; Li J; Chen J; Yao X; Zeng X; Liu Y; Wang Y; Wang X
    Dalton Trans; 2024 Sep; 53(36):15176-15189. PubMed ID: 39221457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Structure and Cytotoxicity of N,N and N,O-Coordinated Ru
    Mukherjee A; Koley TS; Chakraborty A; Purkait K; Mukherjee A
    Chem Asian J; 2021 Nov; 16(22):3729-3742. PubMed ID: 34549886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
    Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
    Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
    Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ
    Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity.
    Biancalana L; Kostrhunova H; Batchelor LK; Hadiji M; Degano I; Pampaloni G; Zacchini S; Dyson PJ; Brabec V; Marchetti F
    Inorg Chem; 2021 Jul; 60(13):9529-9541. PubMed ID: 34156246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.
    Ludwig G; Mojić M; Bulatović M; Mijatović S; Maksimović-Ivanić D; Steinborn D; Kaluđerović GN
    Anticancer Agents Med Chem; 2016; 16(11):1455-1460. PubMed ID: 26510901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.